- Home
- DESP vs KNSA Comparison
DESP vs KNSA Comparison
Compare DESP & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DESP
- KNSA
- Stock Information
- Founded
- DESP 1999
- KNSA 2015
- Country
- DESP British Virgin Islands
- KNSA United Kingdom
- Employees
- DESP N/A
- KNSA N/A
- Industry
- DESP Transportation Services
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- DESP Consumer Discretionary
- KNSA Health Care
- Exchange
- DESP Nasdaq
- KNSA Nasdaq
- Market Cap
- DESP 1.6B
- KNSA 1.4B
- IPO Year
- DESP 2017
- KNSA 2018
- Fundamental
- Price
- DESP $19.27
- KNSA $20.02
- Analyst Decision
- DESP Hold
- KNSA Strong Buy
- Analyst Count
- DESP 5
- KNSA 5
- Target Price
- DESP $17.20
- KNSA $36.60
- AVG Volume (30 Days)
- DESP 1.7M
- KNSA 567.6K
- Earning Date
- DESP 03-13-2025
- KNSA 02-25-2025
- Dividend Yield
- DESP N/A
- KNSA N/A
- EPS Growth
- DESP N/A
- KNSA N/A
- EPS
- DESP N/A
- KNSA N/A
- Revenue
- DESP $756,296,000.00
- KNSA $384,098,000.00
- Revenue This Year
- DESP $10.71
- KNSA $60.10
- Revenue Next Year
- DESP $8.90
- KNSA $34.22
- P/E Ratio
- DESP N/A
- KNSA N/A
- Revenue Growth
- DESP 16.73
- KNSA 54.41
- 52 Week Low
- DESP $8.51
- KNSA $16.56
- 52 Week High
- DESP $19.55
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- DESP 59.23
- KNSA 53.15
- Support Level
- DESP $19.19
- KNSA $19.31
- Resistance Level
- DESP $19.37
- KNSA $20.20
- Average True Range (ATR)
- DESP 0.05
- KNSA 0.80
- MACD
- DESP -0.04
- KNSA 0.06
- Stochastic Oscillator
- DESP 50.00
- KNSA 72.80
About DESP Despegar.com Corp.
Despegar.com Corp is an online travel company in Latin America. Its product offering includes airline tickets, packages, hotels, and other travel-related products, which enables consumers to find, compare, plan and purchase travel products easily through its marketplace. The company provides a technology platform for managing the distribution of products and access to users to the network of travel suppliers. It operates through two segments: Air, which consists of the sale of airline tickets; and Packages, Hotels, and Other Travel Products, which consists of travel packages, as well as sales of hotel rooms, car rentals, bus tickets, cruise tickets, travel insurance and destination services. Its geographical segments are Argentina, Brazil, Uruguay, Mexico, and other countries.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.